Company Profile
Amazing Gut Pty Ltd is an Australia-based developer of home-use pelvic floor biofeedback devices, headquartered in Sydney, NSW 2088, Australia. Founded in April 2025 by Dr Jerry Zhou and A/Prof Vincent Ho as a Western Sydney University spin-out, the company operates as an independent privately-held entity with a small founding team, serving patients with bowel disorders and healthcare providers in Australia with planned global expansion.
Core Products and Technologies
Home Biofeedback Systems
• Ins＆Outs: Wireless home-use pelvic floor exercise biofeedback device with smart sensors and real-time app-guided muscle training for chronic constipation, faecal incontinence and rectal pain/spasms
• Companion App: Android and iOS interface with visual biofeedback, programmable exercises and remote clinician monitoring
• Cloud Monitoring: Data sharing with therapists for remote progress tracking and treatment refinement
Platform Technology
• Smart Sensors: High-sensitivity pressure sensors for simultaneous anal sphincter and rectal pressure measurement
• IoT Connectivity: Wireless data transmission enabling remote clinician access to therapy metrics
• Miniaturized Design: Compact probe form-factor prioritizing comfort and independent home use
Market Position and Certifications
Amazing Gut holds an emerging position in the global home pelvic floor biofeedback market, competing with Laborie and Medtronic traditional clinic-based systems. Key strengths include:
• Research heritage: Rooted in 15+ years of Western Sydney University gut-brain axis research
• Regulatory compliance: TGA Class 1 medical device listed in Australia (ARTG ID 462026, 6 Sep 2024)
• Design excellence: 2024 Good Design Award winner for Medical Product Design
• Published evidence: Clinical trial (Zhou et al. 2024 PLoS ONE) demonstrating improvements in bowel function and symptoms within 6 weeks
• Cost accessibility: AUD $400 home device versus expensive hospital-tethered diagnostics
Corporate Timeline
2019 — Concept originated from a urogynaecologist's question about home biofeedback access
2024 — Received TGA Class 1 approval (ARTG 462026, 6 Sep 2024); won 2024 Good Design Award; published clinical trial in PLoS ONE
2025 — Founded Amazing Gut as a WSU spin-out in April; licensed IP and launched commercial operations; device trialled at Royal Prince Alfred Hospital
2026 — Named one of four recipients of the NSW Medical Devices Fund round to accelerate product scale-up and clinical trials
Target Markets and Applications
• Home Bowel Therapy: Ins＆Outs for patients with chronic constipation, faecal incontinence and rectal pain seeking discreet home treatment
• Remote Clinical Monitoring: Cloud-based data sharing enabling therapists to track patient progress and refine protocols remotely
• Clinical Validation: Royal Prince Alfred Hospital trials and expansion to private physiotherapy practices for real-world evidence generation
Contact Information
Global Headquarters
Address: Sydney, NSW 2088, Australia
Website: www.amazinggut.today
ABN: 73 639 520 657
